Concepedia

J.K. Webb

JW

Statistics

Publications

16

Citations

1.6K

H-Index

14

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Merck Serono Ltd. (United Kingdom)

Merck Canada Inc. (Canada)

United States Military Academy

J.K. Webb is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, neuropharmacology, and medicine.

Publications per year

1994–2005

16

Publications

16

Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn

S. Boyce, A. C. Wyatt, J.K. Webb et al. · Neuropharmacology · 1999 · 338 citations

, , +17

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor

Denis Riendeau, M. David Percival, S. Boyce et al. · British Journal of Pharmacology · 1997 · 326 citations · Full text

, , +13

Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs

N.M.J. Rupniak, Emma Carlson, J.K. Webb et al. · Behavioural Pharmacology · 2001 · 150 citations

, , +17

Functional Properties of the High-Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist (4-Hydroxy-5-iodo-3-methoxyphenylacetate ester) Iodo-Resiniferatoxin

Guy R. Seabrook, Kathy Sutton, Wolfgang Jarolimek et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 128 citations · Full text

, , +17

Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice

N.M.J. Rupniak, Susan Boyce, J.K. Webb et al. · Pain · 1997 · 114 citations

, , +17

1–5 of 16